Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
Top Cited Papers
Open Access
- 1 April 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (7), e61-e65
- https://doi.org/10.1086/500212
Abstract
To evaluate the activity of posaconazole for treatment of zygomycosis, a disease for which therapeutic options are limited, we conducted a retrospectKeywords
This publication has 16 references indexed in Scilit:
- Posaconazole as Salvage Therapy for ZygomycosisAntimicrobial Agents and Chemotherapy, 2006
- Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported CasesClinical Infectious Diseases, 2005
- Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent CasesThe Journal of Infectious Diseases, 2005
- Zygomycosis (mucormycosis): emerging clinical importance and new treatmentsCurrent Opinion in Infectious Diseases, 2004
- Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infectionsInternational Journal Of Clinical Practice, 2004
- Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole TherapyClinical Infectious Diseases, 2003
- In Vivo Activity of Posaconazole againstMucorspp. in an Immunosuppressed-Mouse ModelAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of ZygomycetesAntimicrobial Agents and Chemotherapy, 2002
- Zygomycosis in the 1990s in a Tertiary-Care Cancer CenterClinical Infectious Diseases, 2000
- Zygomycetes in Human DiseaseClinical Microbiology Reviews, 2000